The relationship between the key markers of myocardial fibrosis and gut microbiota composition in patients with heart failure and preserved ejection fraction

28 August 2020 (08:00 - 18:00)

Organised by:

Abstract

Sign in to view the resources

Slides

About the speaker

Doctor Anastasia Kaburova

National Research Center for Preventive Medicine, Moscow (Russian Federation)

274 More presentations in this session

Presentation thumbnail

Increased myocardial fat supply improves cardiac energetics and function in heart failure

Doctor W. Watson (Cambridge, GB)

Abstract Slides

Presentation thumbnail

Cardiac aging is regulated by autophagic disorder mediated by chronic inflammation via the Rubicon/NOX4 pathway.

Doctor T. Kamihara (Obu, JP)

Abstract Slides

Presentation thumbnail

Participants with diabetes have less augmentation in cardiac function and energetics in response to increased supply of fatty acid

Doctor P. Green (Hobart, AU)

Abstract Slides

Presentation thumbnail

Impaired high-density lipoprotein function in patients with heart failure

Ms L. Emmens (Groningen, NL)

Abstract Slides

Presentation thumbnail

The comparison of clinical significance between atrial and ventricular structural remodeling in patients with heart failure with preserved ejection fraction - insights from PURSUIT-HFpEF registry

Doctor M. Okada (Osaka, JP)

Abstract Slides

Access the full session

Session thumbnail

Chronic Heart Failure ePosters

The Event

ESC Congress 2020

28 August 2020 08:00 CET

You may be interested in

Congress Session

Clinical phenotypes of heart failure with preserved ejection fraction

Webinar

Advanced heart failure therapy in HF patients with preserved and mildly reduced ejection fraction

Webinar

Acute heart failure in patients with preserved ejection fraction (AHFPEF)

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources